A detailed history of Ahrens Investment Partners LLC transactions in Viatris Inc stock. As of the latest transaction made, Ahrens Investment Partners LLC holds 165 shares of VTRS stock, worth $1,925. This represents 0.0% of its overall portfolio holdings.

Number of Shares
165
Holding current value
$1,925
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$9.2 - $12.26 $1,517 - $2,022
165 New
165 $1,000
Q1 2022

Apr 28, 2022

SELL
$9.81 - $15.4 $29 - $46
-3 Reduced 1.82%
162 $2,000
Q4 2021

Jan 21, 2022

BUY
$12.09 - $14.68 $1,994 - $2,422
165 New
165 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Ahrens Investment Partners LLC Portfolio

Follow Ahrens Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ahrens Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ahrens Investment Partners LLC with notifications on news.